Radiofrequency ablation is a valuable therapeutic option in the treatment of liver metastases from gastrointestinal stromal tumors

CardioVascular and Interventional Radiology

Volumn 37, Issue 2, 2014, Pages 552-553

  Sun, Qi Kai ^a   Wang, Wei ^a   Jia, Wei Dong ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER SURGERY; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; GASTROINTESTINAL STROMAL TUMOR; HUMAN; LETTER; LIVER METASTASIS; MINIMALLY INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RISK ASSESSMENT; CATHETER ABLATION; FEMALE; LIVER NEOPLASMS; MALE; PATHOLOGY; PROCEDURES;

BENZAMIDE DERIVATIVE; PIPERAZINE DERIVATIVE; PROTEIN KINASE INHIBITOR; PYRIMIDINE DERIVATIVE;

BENZAMIDES; CATHETER ABLATION; FEMALE; GASTROINTESTINAL STROMAL TUMORS; HUMANS; LIVER NEOPLASMS; MALE; PIPERAZINES; PROTEIN KINASE INHIBITORS; PYRIMIDINES;

EID: 84897042156     PISSN: 01741551     EISSN: 1432086X     Source Type: Journal    
DOI: 10.1007/s00270-013-0670-7     Document Type: Letter

References (9)

1. Hakimé A, Le Cesne A, Deschamps F, Farouil G, Boudabous S, Aupérin A et al (2013) A role for adjuvant RFA in managing hepatic metastases from gastrointestinal stromal tumors (GIST) after treatment with targeted systemic therapy using kinase inhibitors. Cardiovasc Intervent Radiol. doi:10.1007/s00270-013-0615-1
2. Decadt B, Siriwardena AK (2004) Radiofrequency ablation of liver tumours: systematic review. Lancet Oncol 5(9):550-560 (Pubitemid 39194044)
3. Chen MS, Li JQ, Zheng Y, Guo RP, Liang HH, Zhang YQ et al (2006) A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 243(3):321-328 (Pubitemid 43327762)
4. Peng ZW, Zhang YJ, Chen MS, Lin XJ, Liang HH, Shi M (2010) Radiofrequency ablation as first-line treatment for small solitary hepatocellular carcinoma: long-term results. Eur J Surg Oncol 36(11):1054-1060
5. Jones RL, McCall J, Adam A, O'Donnell D, Ashley S, Al-Muderis O et al (2010) Radiofrequency ablation is a feasible therapeutic option in the multi modality management of sarcoma. Eur J Surg Oncol 36(5):477-482
6. Shimizu M, Iijima H, Horibe T, Yamada M, Suzuki S, Yanagisawa K et al (2004) Usefulness of contrast-enhanced ultrasonography with a new contrast mode, agent detection imaging, in evaluating therapeutic response in hepatocellular carcinoma treated with radio-frequency ablation therapy. Hepatol Res 29(4):235-242 (Pubitemid 39060778)
7. Kisaka Y, Hirooka M, Koizumi Y, Abe M, Matsuura B, Hiasa Y et al (2010) Contrast-enhanced sonography with abdominal virtual sonography in monitoring radiofrequency ablation of hepatocellular carcinoma. J Clin Ultrasound 38(3):138-144
8. Inoue T, Kudo M, Hatanaka K, Arizumi T, Takita M, Kitai S et al (2013) Usefulness of contrast-enhanced ultrasonography to evaluate the post-treatment responses of radiofrequency ablation for hepatocellular carcinoma: comparison with dynamic CT. Oncology 84(Suppl 1):51-57
9. Joensuu H (2008) Risk stratification of patients diagnosed with gastrointestinal stromal tumor. Hum Pathol 39(10):1411-1419